Skip to main content
Research project

ATTACK - Aspirin To Target Arterial Events in Chronic Kidney Disease

Project overview

Does low-dose aspirin reduce the chance of a first heart attack or stroke in patients with chronic kidney disease (CKD)?

This multicentre randomised trial will assess the effectiveness of low dose aspirin to prevent cardiovascular disease (CVD) in adult patients with chronic kidney disease(CKD). There is uncertainty about the benefits (vs CVD) and harms (bleeding) of aspirin in such patients. CKD is common and the frequency is rising and it is associated with increased risk of CVD.


Other researchers

Professor Joanne Lord

Director of SHTAC

Research interests

  • Health economics
  • Cost-effectiveness analysis
  • Decision modelling

Collaborating research institutes, centres and groups

Research outputs

Hugh G. Gallagher,
Ahmet Fuat,
& Paul Roderick
, 2019 , British Journal of General Practice , 69 (689) , 590--591
Type: letterEditorial
to top